Annual Total Expenses
$11.37 M
-$6.88 M-37.70%
31 March 2024
Summary:
Acasti Pharma annual total expenses is currently $11.37 million, with the most recent change of -$6.88 million (-37.70%) on 31 March 2024. During the last 3 years, it has risen by +$455.00 thousand (+4.17%). ACST annual total expenses is now -66.23% below its all-time high of $33.66 million, reached on 31 March 2019.ACST Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$4.83 M
-$132.00 K-2.66%
30 September 2024
Summary:
Acasti Pharma quarterly total expenses is currently $4.83 million, with the most recent change of -$132.00 thousand (-2.66%) on 30 September 2024. Over the past year, it has increased by +$2.74 million (+130.93%). ACST quarterly total expenses is now -55.49% below its all-time high of $10.85 million, reached on 31 March 2019.ACST Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.7% | +130.9% |
| 3 y3 years | +4.2% | +35.4% |
| 5 y5 years | -66.2% | -22.8% |
ACST Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.7% | +4.2% | -5.4% | +130.9% |
| 5 y | 5 years | -66.2% | +4.2% | -22.8% | +141.3% |
| alltime | all time | -66.2% | +638.9% | -55.5% | +2461.5% |
Acasti Pharma Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.83 M(-2.7%) |
| June 2024 | - | $4.96 M(+52.1%) |
| Mar 2024 | $11.37 M(-37.7%) | $3.26 M(+7.2%) |
| Dec 2023 | - | $3.04 M(+45.5%) |
| Sept 2023 | - | $2.09 M(-29.5%) |
| June 2023 | - | $2.97 M(-28.7%) |
| Mar 2023 | $18.25 M(+19.0%) | $4.17 M(-1.9%) |
| Dec 2022 | - | $4.25 M(-16.9%) |
| Sept 2022 | - | $5.11 M(+8.0%) |
| June 2022 | - | $4.73 M(+7.4%) |
| Mar 2022 | $15.34 M(+40.6%) | $4.40 M(+4.2%) |
| Dec 2021 | - | $4.22 M(+18.4%) |
| Sept 2021 | - | $3.57 M(+13.4%) |
| June 2021 | - | $3.15 M(+57.1%) |
| Mar 2021 | $10.91 M(-55.3%) | $2.00 M(-2.1%) |
| Dec 2020 | - | $2.04 M(-25.5%) |
| Sept 2020 | - | $2.74 M(-33.4%) |
| June 2020 | - | $4.12 M(+2.2%) |
| Mar 2020 | $24.44 M(-27.4%) | $4.03 M(-34.4%) |
| Dec 2019 | - | $6.15 M(-1.7%) |
| Sept 2019 | - | $6.25 M(-21.9%) |
| June 2019 | - | $8.01 M(-26.2%) |
| Mar 2019 | $33.66 M(+120.7%) | $10.85 M(+38.0%) |
| Dec 2018 | - | $7.86 M(-2.7%) |
| Sept 2018 | - | $8.08 M(+7.1%) |
| June 2018 | - | $7.54 M(+38.6%) |
| Mar 2018 | $15.25 M(+81.4%) | $5.44 M(+32.9%) |
| Dec 2017 | - | $4.10 M(+15.9%) |
| Sept 2017 | - | $3.53 M(+64.2%) |
| June 2017 | - | $2.15 M(+15.1%) |
| Mar 2017 | $8.41 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2016 | - | $1.87 M(-0.1%) |
| Aug 2016 | - | $1.87 M(-17.5%) |
| May 2016 | - | $2.27 M(+46.9%) |
| Feb 2016 | $7.09 M(-28.4%) | $1.54 M(-21.8%) |
| Nov 2015 | - | $1.97 M(+20.6%) |
| Aug 2015 | - | $1.64 M(-22.2%) |
| May 2015 | - | $2.10 M(+29.2%) |
| Feb 2015 | $9.91 M(-2.5%) | $1.63 M(-37.7%) |
| Nov 2014 | - | $2.61 M(-17.9%) |
| Aug 2014 | - | $3.18 M(+14.2%) |
| May 2014 | - | $2.79 M(+53.3%) |
| Feb 2014 | $10.16 M(+35.0%) | $1.82 M(-42.2%) |
| Nov 2013 | - | $3.15 M(-5.8%) |
| Aug 2013 | - | $3.34 M(+73.7%) |
| May 2013 | - | $1.92 M(+5.5%) |
| Feb 2013 | $7.53 M(+14.7%) | $1.82 M(-11.6%) |
| Nov 2012 | - | $2.06 M(+3.6%) |
| Aug 2012 | - | $1.99 M(+25.8%) |
| May 2012 | - | $1.58 M(-3.8%) |
| Feb 2012 | $6.56 M(+103.9%) | $1.65 M(-23.1%) |
| Nov 2011 | - | $2.14 M(+19.3%) |
| Aug 2011 | - | $1.80 M(+59.3%) |
| May 2011 | - | $1.13 M(-9.6%) |
| Feb 2011 | $3.22 M(+109.2%) | $1.25 M(+61.6%) |
| Nov 2010 | - | $772.20 K(+20.3%) |
| Aug 2010 | - | $641.70 K(+25.2%) |
| May 2010 | - | $512.60 K(+22.1%) |
| Feb 2010 | $1.54 M | $419.80 K(+10.9%) |
| Nov 2009 | - | $378.60 K(-16.1%) |
| Aug 2009 | - | $451.30 K(+70.6%) |
| May 2009 | - | $264.50 K(+40.2%) |
| Nov 2008 | - | $188.60 K |
FAQ
- What is Acasti Pharma annual total expenses?
- What is the all time high annual total expenses for Acasti Pharma?
- What is Acasti Pharma annual total expenses year-on-year change?
- What is Acasti Pharma quarterly total expenses?
- What is the all time high quarterly total expenses for Acasti Pharma?
- What is Acasti Pharma quarterly total expenses year-on-year change?
What is Acasti Pharma annual total expenses?
The current annual total expenses of ACST is $11.37 M
What is the all time high annual total expenses for Acasti Pharma?
Acasti Pharma all-time high annual total expenses is $33.66 M
What is Acasti Pharma annual total expenses year-on-year change?
Over the past year, ACST annual total expenses has changed by -$6.88 M (-37.70%)
What is Acasti Pharma quarterly total expenses?
The current quarterly total expenses of ACST is $4.83 M
What is the all time high quarterly total expenses for Acasti Pharma?
Acasti Pharma all-time high quarterly total expenses is $10.85 M
What is Acasti Pharma quarterly total expenses year-on-year change?
Over the past year, ACST quarterly total expenses has changed by +$2.74 M (+130.93%)